Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-11-15
2026-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smartphone Services for Stimulant Use Disorder
NCT07092059
Substance Abuse Pre-Treatment Screening Study
NCT00439049
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
NCT02034201
Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
NCT05854667
Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
NCT06788587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LDART
Participants will be given access to LDART for 28 days.
LDART
Let's Do Addiction Recovery Together! (LDART) is a web-based intervention designed to be used for a few minutes each night to reduce problematic substance use. It has three active ingredients: 1) daily recovery goal setting and tracking, 2) motivational video, audio, and written messages from individuals in recovery, and 3) information on several community-based addiction recovery groups (e.g., support groups).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LDART
Let's Do Addiction Recovery Together! (LDART) is a web-based intervention designed to be used for a few minutes each night to reduce problematic substance use. It has three active ingredients: 1) daily recovery goal setting and tracking, 2) motivational video, audio, and written messages from individuals in recovery, and 3) information on several community-based addiction recovery groups (e.g., support groups).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently reside in Connecticut, USA
* Have a smartphone that can send and receive text messages and have internet access that can be access over the course of a month
* Substance (Stimulant) Use Symptom Checklist ≥2, indicating past-year stimulant use disorder
* Had high frequency of cocaine use (≥5 days) in the past 28 days
* Have some self-reported desire to cut down or quit stimulants
Exclusion Criteria
* Unable to speak, read, or write in English
* Vulnerable population status
* Unlikely to be able to complete study procedures in the next 2-3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
College on Problems of Drug Dependence
UNKNOWN
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Yan McCurdy, PhD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EarlyCareer Investigator grant
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2000040872
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.